Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

The treatment was ineffective in humans.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Hedgehog signaling controls hair follicle development and can affect skin cancer growth.

CD4+ skin cells may be precursors to basal cell carcinoma.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Cells from certain embryo parts can induce head formation in another embryo, involving complex signaling pathways.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.